Cadila Healthcare Q1 net profit dips 15% to Rs 132.7cr

By Admin
Share
Cadila Healthcare Wednesday said it has reported a 15% fall in its net profit during the first quarter of the current fiscal ended June 30 at Rs132.7 c...

Cadila Healthcare Wednesday said it has reported a 15% fall in its net profit during the first quarter of the current fiscal ended June 30 at Rs132.7 crore, as against Rs  152.9 crore registered in the corresponding quarter last fiscal.

Net sales of pharma major during the quarter rose by 4.8% on a year-on-year basis to Rs 819.4 crore.  

The drug maker’s expenditure during the quarter also rose to Rs 628.5 crore in FY 13 from Rs 591.4 crore in FY12.  Cadila's employee cost rose to Rs 127 crore in Q1 of 2012-13 to Rs 99.9 crore in the first quarter of 2011-12.

On a consolidated basis, Cadila Healthcare reported sales of Rs 1,547 crore, an increase by 30% . On the other hand, in the corresponding quarter of the previous fiscal, the company reported sales of Rs 1,189 crore.  

In the domestic formulations market, Cadila Healthcare reported sales of Rs 582 crore, up by 27%. The pharma company also launched 30 new products including the line extensions, of which 10 products were first to be launched in India.

Meanwhile, during the quarter, Cadila Healthcare's  revenues were driven by 50% year-on-year growth in the U.S. business and 37% growth in Brazil. The exports of the emerging markets also rose by 84%.  

With the recent approval from USFDA for its facility at Moraiya, Cadila also aims to start getting new product approvals, which will also strengthen its U.S. business.  It also strengthened its regulatory pipeline and also filed nine abbreviated new drug applications including 2 for injectible products, taking the cumulative number of US ANDA filings to 157.

Cadila Healthcare is the pharmaceutical company headquartered at Ahmedabad in Gujarat. It is the fifth largest pharmaceutical company in India and is the largest manufacturer of generic drugs.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma